ELCIX
Price
$50.75
Change
+$0.47 (+0.93%)
Updated
Oct 8 closing price
Net Assets
458.98M
RGACX
Price
$86.09
Change
+$0.64 (+0.75%)
Updated
Oct 8 closing price
Net Assets
340.58B
Interact to see
Advertisement

ELCIX vs RGACX

Header iconELCIX vs RGACX Comparison
Open Charts ELCIX vs RGACXBanner chart's image
Eaton Vance Growth I
Price$50.75
Change+$0.47 (+0.93%)
VolumeN/A
Net Assets458.98M
American Funds Growth Fund of Amer R3
Price$86.09
Change+$0.64 (+0.75%)
VolumeN/A
Net Assets340.58B
ELCIX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
ELCIX vs. RGACX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELCIX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 341B vs. ELCIX (459M). RGACX pays higher dividends than ELCIX: RGACX (0.07) vs ELCIX (0.00). ELCIX was incepted earlier than RGACX: ELCIX (18 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than ELCIX (0.79). RGACX is a more actively managed with annual turnover of: 25.00 vs. ELCIX (18.00). RGACX has a lower initial minimum investment than ELCIX: RGACX (250) vs ELCIX (1000000). RGACX annual gain was more profitable for investors over the last year : 14.19 vs. ELCIX (11.78). RGACX (40.04) and ELCIX (39.55) have equivalent 5 years return.
ELCIXRGACXELCIX / RGACX
Total Expense Ratio0.790.9484%
Annual Report Gross Expense Ratio0.790.9484%
Fund Existence18 years23 years-
Gain YTD13.57619.58669%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets459M341B0%
Annual Yield % from dividends0.000.07-
Returns for 1 year11.7814.1983%
Returns for 3 years75.0774.27101%
Returns for 5 years39.5540.0499%
Returns for 10 years125.27101.32124%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATXS8.400.93
+12.45%
Astria Therapeutics
SCNI1.630.17
+11.64%
Scinai Immunotherapeutics Ltd.
KLIC40.730.68
+1.70%
Kulicke and Soffa Industries
UCL2.30N/A
N/A
uCloudlink Group
HTHT37.78-0.28
-0.74%
H World Group Limited